Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,246 | -4,899 | -3,430 | -3,918 | -2,419 |
| Depreciation Amortization | 1,130 | 97 | 157 | 153 | 162 |
| Accounts receivable | -93 | -155 | -426 | 105 | -400 |
| Other Working Capital | 1,688 | 21 | -417 | -19 | -307 |
| Other Operating Activity | 2,034 | 882 | 1,181 | 1,456 | 895 |
| Operating Cash Flow | $-4,487 | $-4,054 | $-2,935 | $-2,223 | $-2,069 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,290 | 2,769 | -2,750 | N/A | N/A |
| PPE Investments | -161 | -108 | -90 | -48 | -5 |
| Purchase Of Investment | 1 | -5 | N/A | -16 | 6 |
| Investing Cash Flow | $-4,450 | $2,656 | $-2,840 | $-64 | $1 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -46 |
| Common Stock Issued | 10,285 | 3,584 | 5,169 | 4,117 | 2,206 |
| Other Financing Activity | -600 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $9,685 | $3,584 | $5,169 | $4,117 | $2,160 |
| Beginning Cash Position | 3,503 | 1,317 | 1,923 | 93 | 1 |
| End Cash Position | 4,251 | 3,503 | 1,317 | 1,923 | 93 |
| Net Cash Flow | $748 | $2,186 | $-606 | $1,830 | $92 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,487 | -4,054 | -2,935 | -2,223 | -2,069 |
| Capital Expenditure | -161 | -108 | -90 | -48 | -5 |
| Free Cash Flow | -4,648 | -4,162 | -3,025 | -2,271 | -2,074 |